Evidence map›Paper›PMID 36916999›Full record

ArticleCancer science2023

Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance.

Shinya Sato, Toru Hiruma, Mitsuyuki Koizumi, Mitsuyo Yoshihara, Yoshiyasu Nakamura, Hiroko Tadokoro, Sadako Motomatsu, Takashi Yamanaka, Kota Washimi, Yoichiro Okubo and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Immune mediated support of metastasis: Implication for bone invasion.Cancer communications (London, England) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Metabolomics combined with mathematical analysis reveals metabolic pathways specific to metastatic cancers.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Shinya SatoMorphological Information Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama, Japan.ORCID https://orcid.org/0000-0002-2155-2379
Toru HirumaDepartment of Musculoskeletal Tumor Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Mitsuyuki KoizumiDepartment of Urology, Kanagawa Cancer Center, Yokohama, Japan.
Mitsuyo YoshiharaMorphological Information Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Yoshiyasu NakamuraMorphological Information Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Hiroko TadokoroMolecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Sadako MotomatsuMorphological Information Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Takashi YamanakaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kota WashimiDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Yoichiro OkuboDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Emi YoshiokaDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Rika KasajimaMolecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Toshinari YamashitaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Takeshi KishidaDepartment of Urology, Kanagawa Cancer Center, Yokohama, Japan.
Tomoyuki YokoseDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Yohei MiyagiMolecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Kanagawa Prefectural Hospital Organization · JP

Funding

Foundation for Promotion of Cancer ResearchJapan Society for the Promotion of Science JP20K09422Takeda Medical Research Foundation
6 · The paper itself

Abstract

Bone metastasis occurs frequently in cancer patients. Conventional therapies have limited therapeutic outcomes, and thus, exploring the mechanisms of cancer progression in bone metastasis is important to develop new effective therapies. In the bone microenvironment, adipocytes are the major stromal cells that interact with cancer cells during bone metastasis. However, the comprehensive functions of bone marrow adipocytes in cancer progression are not yet fully understood. To address this, we investigated the role of bone marrow adipocytes on cancer cells, by focusing on an invasive front that reflects the direct effects of stromal cells on cancer. In comprehensive histopathological and genetic analysis using bone metastasis specimens, we examined invasive fronts in bone metastasis and compared invasive fronts with adipocyte-rich bone marrow (adipo-BM) to those with hematopoietic cell-rich bone marrow (hemato-BM) as a normal counterpart of adipocytes. We found morphological complexity of the invasive front with adipo-BM was significantly higher than that with hemato-BM. Based on immunohistochemistry, the invasive front with adipo-BM comparatively had a significantly increased cancer-associated fibroblast (CAF) marker-positive area and lower density of CD8

Indexed as

Bone NeoplasmsCancer-Associated FibroblastsAdipocytesBone MarrowBone Marrow CellsHumansImmune EvasionStromal CellsTumor Microenvironmentadipocytebone marrowbone metastasisdrug resistanceinvasive front

Identifiers

PMID36916999
PMCPMC10236619
OpenAlexW4324129860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.